Laskin, Benjamin L.
Huang, Guixia
King, Eileen
Geary, Denis F.
Licht, Christoph
Metlay, Joshua P.
Furth, Susan L.
Kimball, Tom
Mitsnefes, Mark
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK101600, K24DK090070)
Fresenius Medical North America
National Cancer Institute (1KM1CA156715-01)
Article History
Received: 10 October 2016
Revised: 8 March 2017
Accepted: 9 March 2017
First Online: 8 April 2017
Compliance with ethical standards
: Written consent was obtained from all participants or their parents/guardians and all participants also provided assent. The study was approved by the separate Institutional Review Boards at the three centers and was registered on ClinicalTrials.gov (NCT01352455).
: Dr. Laskin has served as a site principal investigator for industry-sponsored studies by Amgen, Genzyme, and Vifor Pharma.